α-Tocopherol enhances tumour growth inhibition by cis-dichlorodiaminine platinum (II)

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 8, 2000, Pages 929-936

  Sarna, S ^a   Kumar, A ^a   Bhola, R K ^a  

^a GAUHATI UNIVERSITY   (India)

Author keywords

Cisplatin; Dalton's lymphoma; Tumour growth inhibition; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CISPLATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; MALE; MOUSE; NONHUMAN; SURVIVAL RATE;

ANIMALIA;

EID: 0033866060     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000800009     Document Type: Article

References (48)

1. Enhanced cell mediated immunity in mice after cisplatin treatment
2. Activation of human peripheral blood derived monocytes by cis-diamminedichloroplatinum: Enhanced tumoricidal activity and secretion of tumour necrosis factor-alpha
3. Chemoimmunotherapeutical study on a fibrosarcoma with cis-dichlorodiammine platinum (II)
4. A possible mechanism of tumour regression in cisplatin treated mice
5. Potentiation of antitumour activity of cisplatin in mice by 3-aminobenzamide and nicotinamide
6. The effects of co-administration of selenium and cisplatin (CDDP) on CDDP-induced toxicity and antitumor activity
7. Cisptatin and nifedipine: Synergistic antitumor effect against an inherently cisplatin-resistant tumor
8. Chloroquine enhances the cytotoxicity of cis-diammine-dichloroplatinum II
9. Combination therapy of transplantable tumour in mice with cisplatin and glucose
10. Chemoimmunotherapeutical study on Dalton's lymphoma in mice using cisplatin and ascorbic acid: Synergistic antitumour effect in vivo and in vitro
11. 4 rat glioma in vitro and in vivo
12. Interaction between the kinetics of thermotolerance and effect of cis-diamminedichloroplatinum (II) or bleomycin given at 37°or 43°C
13. Synergistic cytotoxic action of cisplatin and liposomal valinomycin on human ovarian carcinoma cells
14. Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and paplomycin)
15. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms
16. Suppression of X-ray induced transformation by vitamin E in mouse C3H10T1/2 cells
17. Vitamin E acts as a useful chemopreventive agent to reduce spontaneous lung tumorigenesis in mice
18. Modification of the effect of the pharmacological agents, ionizing radiation and hyperthermia on tumour cells by vitamin E
19. dl-α-Tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells
20. Vitamin E increases the growth inhibitory and differentiating effect of tumor therapeutic agent on neuroblastoma and glioma cells in culture
21. Combined effect of vitamin E (α-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo
22. Combination chemotherapy of refractory lymphoma with cis-dichlorodiamineplatinum, vinblastine, and bleomycin
23. Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors
24. Vitamins induce cell differentiation, growth inhibition and enhance the effect of tumor therapeutic agents on some cancer cells in vitro
25. Effect of dl-α-tocopherol (vitamin E) on the differentiation of mouse myeloid leukemia cells
26. Inhibition of differentiation of mouse myeloid leukemia cells by phenolic antioxidants and α-tocopherol
27. Antitumor proliferation properties of vitamin E
28. Growth inhibitory effects of vitamin E succinate on retrovirus transformed tumor cells in vitro
29. Vitamin E succinate inhibits protein kinase C: Correlation with its unique inhibitory effects on cell growth and transformation
30. Cellular responses to cisplatin: The roles of DNA binding proteins and DNA repairs
31. Hyperthermia induces apoptosis in malignant fibrous histiocytoma cells in vitro
32. Release of protein bound sialic acid from fibrosarcoma cells after cis-dichlorodiammine platinum (II) treatment: The possible role in tumor regression
33. Cytological changes in ascites Dalton's lymphoma in mice after treatment with cis-dichlorodiammine platinum (II) and α-tocopherol
34. Combined effect of cisplatin and α-tocopherol on mice bearing Dalton's lymphoma
35. The binding of cis-dichlorodiammineplatinum (II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro
36. Antitumor effects of vitamin A and inhibitors of ornithine decarboxylase in cultured neuroblastoma and glioma cells
37. Human neuroblastoma cells and 13-cis-retinoic acid
38. Synergistic combination therapy of 5-fluorouracil, vitamin A and cobalt-60 radiation upon head and neck tumours
39. Effects of retinoic acid on the growth and phenotypic expression of several human neuroblastoma cell lines
40. Mechanism of cis-diamminedichloro platinum (II)-induced cytotoxicity: Role of G2 arrest and DNA double-strand breaks
41. The interaction of antitumor platinum compounds with cellular DNA in cultured cells and tissues: Relationship to DNA cellular repair processes
42. The interaction of antitumor platinum complex with DNA
43. Cisplatin and DNA repair in cancer chemotherapy
44. DNA crosslinking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum (II) and L-phenylalanine mustard
45. Binding of vitamin E in mammalian tumour cells in culture
46. Ultrastructure and cell surface studies of cancer cells following vitamin C administration
47. Effect of vitamin E as an immunopotentiating agent for mice at optimum doses and its toxicity at high dosage
48. Vitamin E and cancer treatment - Experimental studies in mice